<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00466999</url>
  </required_header>
  <id_info>
    <org_study_id>2.2.2</org_study_id>
    <nct_id>NCT00466999</nct_id>
  </id_info>
  <brief_title>Sublingual Misoprostol Versus Standard Surgical Care for the Treatment of Incomplete Abortion</brief_title>
  <official_title>Sublingual Misoprostol Versus Standard Surgical Care for the Treatment of Incomplete Abortion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gynuity Health Projects</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gynuity Health Projects</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, we will compare the safety and efficacy of 400 mcg sublingually administered
      misoprostol alone to standard surgical care for the treatment of incomplete abortion. This
      study will provide important data on the role of misoprostol in health services offering an
      array of treatments for incomplete abortion. Women could significantly benefit from a
      non-invasive treatment option for incomplete abortion. While safe surgical services are
      becoming more widespread, there is still a serious risk of complications from these
      procedures. Especially in developing countries, infection, hemorrhage and uterine damage are
      still too common. Medical treatment of incomplete abortion using misoprostol would be a
      tremendous step to reducing morbidity and mortality due to abortion complications.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2007</start_date>
  <completion_date type="Actual">November 2009</completion_date>
  <primary_completion_date type="Actual">November 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Complete abortion without recourse to surgical intervention.</measure>
    <time_frame>follow up visit 7 days after initial treatment</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1000</enrollment>
  <condition>Incomplete Abortion</condition>
  <arm_group>
    <arm_group_label>surgery</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>standard surgical treatment (either dilation and curettage or manual vacuum aspiration)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>misoprostol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>400 mcg misoprostol</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>misoprostol</intervention_name>
    <description>single dose of 400 mcg misoprostol administered sublingually</description>
    <arm_group_label>misoprostol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>surgery</intervention_name>
    <description>standard surgical treatment (dilation and curettage or manual vacuum aspiration)</description>
    <arm_group_label>surgery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Uterine size no larger than 12 weeks LMP at time of presentation for care.

          -  Past or present history of vaginal bleeding during pregnancy.

          -  Open cervical os.

          -  If ultrasound used evidence of incomplete abortion with substantial debris in the
             uterus.

          -  All women would have been advised to have surgical evacuation of the uterus if
             misoprostol was not available.

          -  General good health.

          -  Willing to provide contact information for purposes of follow-up.

          -  Also in Egypt: 21 years of age or over or parental permission (there is no minimum age
             requirement in Niger, Mauritania and Senegal).

        Exclusion Criteria:

          -  Contraindications to study drug

          -  Signs of severe infection, defined as at least one of the following: 1) foul smelling
             discharge, 2) fever &gt; 38 degrees C , 3) uterine tenderness

          -  Hemodynamic disturbances (pulse &gt;110/min and systolic bp &lt;100)

          -  Have an IUD in place; (the IUD may be removed making the woman eligible)

          -  Suspected ectopic pregnancy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Beverly Winikoff, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gynuity Health Projects</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rasha Dabash, MPH</last_name>
    <role>Study Director</role>
    <affiliation>Gynuity Health Projects</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ayisha Diop, MPH</last_name>
    <role>Study Director</role>
    <affiliation>Gynuity Health Projects</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dandé District Hospital/Ziniaré District Hospital</name>
      <address>
        <city>Dande/Ziniare</city>
        <country>Burkina Faso</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>El-Galaa Teaching Hospital</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shatby Maternity Hospital/Alexandria University</name>
      <address>
        <city>Shatby, Alexandria</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cheikh Zayed Hospital</name>
      <address>
        <city>Nouakchott</city>
        <country>Mauritania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maternite Issaka Gazobi</name>
      <address>
        <city>Niamey</city>
        <country>Niger</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre de Sante Le Roi Baudouin</name>
      <address>
        <city>Guediawaye</city>
        <country>Senegal</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Burkina Faso</country>
    <country>Egypt</country>
    <country>Mauritania</country>
    <country>Niger</country>
    <country>Senegal</country>
  </location_countries>
  <link>
    <url>http://www.gynuity.org</url>
  </link>
  <verification_date>March 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 25, 2007</study_first_submitted>
  <study_first_submitted_qc>April 25, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 27, 2007</study_first_posted>
  <last_update_submitted>March 28, 2012</last_update_submitted>
  <last_update_submitted_qc>March 28, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 30, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>misoprostol</keyword>
  <keyword>incomplete abortion</keyword>
  <keyword>PAC</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Abortion, Incomplete</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Misoprostol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

